Literature DB >> 23786824

Lipoprotein (a), metabolic syndrome and coronary calcium score in a large occupational cohort.

K-C Sung1, S H Wild, C D Byrne.   

Abstract

BACKGROUND AND AIMS: Whether lipoprotein (a) [Lp(a)] concentration is associated with metabolic syndrome (MetS) and pre-clinical atherosclerosis in different ethnic groups is uncertain. The association between Lp(a), MetS and a measure of pre-clinical atherosclerosis was studied in a large Asian cohort. METHODS AND
RESULTS: Data were analyzed from a South Korean occupational cohort who underwent a cardiac computed tomography (CT) estimation of CAC score and measurements of cardiovascular risk factors (n = 14,583 people). The key exposure was an Lp(a) concentration in the top quartile (>38.64 mg/dL)) with a CAC score >0 as the outcome variable and measure of pre-clinical atherosclerosis. Logistic regression was used to describe the associations. 1462 participants had a CAC score >0. In the lowest Lp(a) quartile (<11.29 mg/dL), 25.8% had MetS, compared with 16.1% in the highest Lp(a) quartile (>38.64 mg/dL (p < 0.001). MetS, and component features, were inversely related to Lp(a) concentration (all p < 0.0001). In the highest Lp(a) quartile group, there was an association between Lp(a) and CAC score >0 in men (OR 1.21[1.05, 1.40], p = 0.008), and women (OR 1.62[1.03, 2.55], p = 0.038), after adjustment for age, sex, lipid lowering therapy, and multiple cardiovascular risk factors. There was no evidence of an interaction between highest quartile Lp(a) and either high LDLc (>147 mg/dL) (p = 0.99), or MetS (p = 0.84) on the association with CAC score >0.
CONCLUSION: Lp(a) levels are inversely related to MetS and its components. There was a robust association between Lp(a) concentration >38.6 mg/dL and marker of early atherosclerosis in both men and women, regardless of LDLc, level MetS or other cardiovascular risk factors.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; BMI; CAC; CVD; Cardio-metabolic risk factors; Cardiovascular disease (CVD); Coronary artery calcium (CAC) score; DBP; FRS; Framingham Risk Score; HDLc; Lp(a); MetS; Metabolic syndrome (MetS); SBP; TG; body mass index; cardiovascular disease; coronary artery calcium score; diastolic blood pressure; high density lipoprotein cholesterol; metabolic syndrome; systolic blood pressure; triglyceride

Mesh:

Substances:

Year:  2013        PMID: 23786824     DOI: 10.1016/j.numecd.2013.02.009

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  9 in total

1.  Association of sex-specific differences in lipoprotein(a) concentrations with cardiovascular mortality in individuals with type 2 diabetes mellitus.

Authors:  Marcello Ricardo Paulista Markus; Till Ittermann; Sabine Schipf; Martin Bahls; Matthias Nauck; Henry Völzke; Raul Dias Santos; Annette Peters; Tanja Zeller; Stephan Burkhard Felix; Ramachandran S Vasan; Barbara Thorand; Elisabeth Steinhagen-Thiessen; Marcus Dörr
Journal:  Cardiovasc Diabetol       Date:  2021-08-18       Impact factor: 9.951

2.  Study on the relationship between hormone and Lp(a) in Chinese overweight/obese patients.

Authors:  Xiaona Chang; Nannan Bian; Xiaoyu Ding; Jinman Li; Yu An; Jiaxuan Wang; Jia Liu; Guang Wang
Journal:  BMC Endocr Disord       Date:  2022-05-16       Impact factor: 3.263

3.  Lipoprotein(a) Change After Sleeve Gastrectomy Is Affected by the Presence of Metabolic Syndrome.

Authors:  Silvia Paredes; Marta Alves; Maria Lopes Pereira; Olinda Marques; Laura Ribeiro
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

4.  Coronary calcification is associated with elevated serum lipoprotein (a) levels in asymptomatic men over the age of 45 years: A cross-sectional study of the Korean national health checkup data.

Authors:  Young Hak Chung; Byoung-Kwon Lee; Hyuck Moon Kwon; Pil-Ki Min; Eui-Young Choi; Young Won Yoon; Bum-Kee Hong; Se-Joong Rim; Jong-Youn Kim
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

5.  Lipoprotein(a) and Metabolic Syndrome.

Authors:  Nikolaus Buchmann; Till Ittermann; Ilja Demuth; Marcello R P Markus; Henry Völzke; Marcus Dörr; Nele Friedrich; Markus M Lerch; Raul D Santos; Sabine Schipf; Elisabeth Steinhagen-Thiessen
Journal:  Dtsch Arztebl Int       Date:  2022-04-15       Impact factor: 8.251

6.  Metabolic syndrome criteria as predictors of subclinical atherosclerosis based on the coronary calcium score.

Authors:  Mi Hae Seo; Eun-Jung Rhee; Se Eun Park; Cheol Young Park; Ki Won Oh; Sung Woo Park; Won-Young Lee
Journal:  Korean J Intern Med       Date:  2014-12-30       Impact factor: 2.884

Review 7.  Importance of Coagulation Factors as Critical Components of Premature Cardiovascular Disease in Familial Hypercholesterolemia.

Authors:  Uffe Ravnskov; Michel de Lorgeril; Malcolm Kendrick; David M Diamond
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

8.  Correlations Between Coronary Artery Disease, Coronary Artery Calcium Score, and Lipoprotein(a) Level in Korea.

Authors:  Joan Kim; Seung Woo Choi; Young Shin Lee; Jung Myung Lee; Hyemoon Chung; Jong Shin Woo; Woo-Shik Kim; Yun Young Choi; Weon Kim
Journal:  Ther Clin Risk Manag       Date:  2022-10-01       Impact factor: 2.755

Review 9.  Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians.

Authors:  Enas A Enas; Basil Varkey; T S Dharmarajan; Guillaume Pare; Vinay K Bahl
Journal:  Indian Heart J       Date:  2019-05-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.